850991-33-2 Usage
Uses
Used in Organic Synthesis:
5-PHENOXY-3-PYRIDINYL)BORONICACID is used as a building block for the development of various pharmaceuticals and agrochemicals. Its boronic acid functionality enables it to engage in Suzuki-Miyaura cross-coupling reactions, which are crucial for constructing carbon-carbon bonds in organic synthesis.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-PHENOXY-3-PYRIDINYL)BORONICACID is utilized as a key intermediate in the synthesis of drugs. Its unique structure and reactivity make it a valuable component in the creation of novel therapeutic agents.
Used in Agrochemical Industry:
5-PHENOXY-3-PYRIDINYL)BORONICACID is also used as a precursor in the synthesis of agrochemicals, contributing to the development of new pesticides and other agricultural products.
Used in Therapeutic Applications:
5-PHENOXY-3-PYRIDINYL)BORONICACID is considered a potential therapeutic agent for the treatment of various diseases, including cancer and neurological disorders. Its specific properties and interactions with biological targets make it a promising candidate for further research and development in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 850991-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,9,9 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 850991-33:
(8*8)+(7*5)+(6*0)+(5*9)+(4*9)+(3*1)+(2*3)+(1*3)=192
192 % 10 = 2
So 850991-33-2 is a valid CAS Registry Number.
850991-33-2Relevant academic research and scientific papers
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RELIEVING PAIN AND TREATING CENTRAL NERVOUS SYSTEM DISORDERS
-
Page/Page column 105, (2008/06/13)
Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia), are treated by administering a compound of Formulas (1 or 2), as described herein. The compounds of Formulas (1 and 2) are also useful for treating pain, and treating drug addiction, nicotine addiction, and/or obesity. The compounds can exist as individual stereoisomers, racemic mixtures, diastereomers and the like.
